Literature DB >> 29180192

Reduced serum cholinesterase activity indicates splenic modulation of the sterile inflammation.

Aleksandar R Zivkovic1, Kevin M Tourelle2, Thorsten Brenner2, Markus A Weigand2, Stefan Hofer3, Karsten Schmidt2.   

Abstract

BACKGROUND: Sterile inflammation is an immediate and well-coordinated immune response to surgical injury. The cholinergic system plays a pivotal role in the inflammatory response. Induced inflammation stimulates the vagus nerve, which in turn activates anti-inflammatory nonneuronal processes. Serum cholinesterase (butyrylcholinesterase [BChE]) is an enzyme that hydrolyzes acetylcholine. Measuring the activity of the BChE in blood might indicate the level of the nonneuronal cholinergic activity. The spleen is a major organ of the immune system playing an important role during inflammation. A functional connection of the neuroimmune reflex has thus far been described only in experimental settings.
MATERIALS AND METHODS: In 48 patients receiving major pancreatic surgery, BChE activity was measured by applying point-of-care-testing, in addition to standard laboratory tests.
RESULTS: The BChE activity decreased in patients receiving surgery. This reduction emerged much earlier than changes in C-reactive protein concentration, an inflammatory biomarker broadly used in the clinical environment. A milder reduction in the BChE activity was observed in patients subjected to surgery with splenectomy than in those with a preserved spleen.
CONCLUSIONS: The use of the point-of-care-testing system for quick bedside diagnostics and the rapid effects of inflammation on BChE levels provide a method and a marker to facilitate the early detection of systemic inflammation. Furthermore, this study provides evidence that the experimentally documented neuroimmune interaction is part of the physiological response to surgery-induced sterile inflammation. Splenic function plays an essential role in modulating the cholinergic anti-inflammatory response.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; Diagnosis; Infection; Pseudocholinesterase; SIRS; Sepsis

Mesh:

Substances:

Year:  2017        PMID: 29180192     DOI: 10.1016/j.jss.2017.07.024

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome.

Authors:  Carmel Therese Harrington; Naz Al Hafid; Karen Ann Waters
Journal:  EBioMedicine       Date:  2022-05-06       Impact factor: 11.205

2.  Comment on "A Sustained Reduction in Serum Cholinesterase Enzyme Activity Predicts Patient Outcome following Sepsis".

Authors:  Carlo Chiarla; Ivo Giovannini
Journal:  Mediators Inflamm       Date:  2019-04-23       Impact factor: 4.711

3.  Different Pharmacokinetics of Tramadol, O-Demethyltramadol and N-Demethyltramadol in Postoperative Surgical Patients From Those Observed in Medical Patients.

Authors:  Nenad Neskovic; Dario Mandic; Saska Marczi; Sonja Skiljic; Gordana Kristek; Hrvoje Vinkovic; Boris Mraovic; Zeljko Debeljak; Slavica Kvolik
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

4.  Prospective, observational, single-centre cohort study with an independent control group matched for age and sex aimed at investigating the significance of cholinergic activity in patients with schizophrenia: study protocol of the CLASH-study.

Authors:  Benedikt Schick; Eberhard Barth; Benjamin Mayer; Claire-Louise Weber; Theresa Hagemeyer; Carlos Schönfeldt
Journal:  BMJ Open       Date:  2021-12-20       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.